Brian M Shuch MD
Minimally Invasive Surgery, Surgical Oncology
Associate Professor of Urology, Director of the UCLA Kidney Cancer Program
Join to View Full Profile
200 Medical Plaza, Suite 140Los Angeles, CA 90095
Phone+1 310-206-8164
Fax+1 310-206-8164
Dr. Shuch is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Professor of Urology,
Director of the UCLA Kidney Cancer Program
Education & Training
National Institutes of Health Clinical CenterFellowship, Minimally Invasive Urologic Surgery, 2010 - 2013
UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Urology, 2005 - 2010- UCLA David Geffen School of Medicine/UCLA Medical CenterInternship, Transitional Year, 2004 - 2005
New York University School of MedicineClass of 2004
Certifications & Licensure
CA State Medical License 2006 - 2026
CT State Medical License 2013 - 2019
American Board of Urology Urology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2014
Clinical Trials
- Active Surveillance of the Small Renal Mass Start of enrollment: 2014 Dec 01
- Nivolumab in Treating Patients With Localized Kidney Cancer Undergoing Nephrectomy Start of enrollment: 2017 Apr 28
- SPECT/CT for the Characterization of Renal Masses Start of enrollment: 2018 Dec 07
- Join now to see all
Publications & Presentations
PubMed
- ELOC-Mutated Renal Cell Carcinoma is a Rare Indolent Tumor with Distinctive Genomic Characteristics.Jasmine J Wang, Rong Rong Huang, Brian D Cone, Sung-Hae L Kang, Reza Setoodeh
Modern Pathology. 2025-04-15 - Clinical and genetic characteristics in two cases of Birt-Hogg-Dubé syndrome associated with papillary renal cell carcinoma and rare Folliculin (FLCN) variants.Mark G Evans, Logan W Thomas, Manando Nakasaki, Ahmad Charifa, Anthony Sisk
Cancer Genetics. 2025-04-01 - 1 citationsImpact of postprogression therapies on overall survival: Recommendations from the 2023 kidney cancer association think tank meeting.Stephanie A Berg, Salvatore La Rosa, Tian Zhang, Phillip M Pierorazio, Laurence Albiges
Urologic Oncology. 2025-03-01
Journal Articles
- Krebs-Cycle-Deficient Hereditary Cancer Syndromes Are Defined by Defects in Homologous-Recombination DNA RepairBrian Shuch, Ranjit S Bindra, Christopher D Corso, Peter M Glazer, Nature
Authored Content
- Decisional Regret and Financial Toxicity Among Patients with Benign Renal MassesOctober 2021
Press Mentions
UCLA’s Multidisciplinary Program Transforms the Outlook for People with Von Hippel-Lindau DiseaseNovember 25th, 2024- Novel Imaging Technique Accurate for Detecting Clear-Cell Renal Cell CancerOctober 22nd, 2024
- New Imaging Technique Accurately Detects Aggressive Kidney Cancer, Claims StudyOctober 21st, 2024
- Join now to see all
Committees
- Member, NCI PDQ Kidney Cancer Board
- Kidney Cancer Committee, Society of Urologic Oncology Clinical Trials Consortium
- Co-PI of S1500 Trial, SWOG Genitourinary Cancer Group
Professional Memberships
- Member
- Member
- Society of Urologic Oncology (SUO)Member
External Links
- Faculty Pagehttps://www.uclahealth.org/brian-shuch
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
